WallStreetZenWallStreetZen

NASDAQ: CLSD
Clearside Biomedical Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CLSD past revenue growth

How has CLSD's revenue growth performed historically?
Company
519.89%
Industry
149.51%
Market
17.15%
CLSD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CLSD's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CLSD's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CLSD earnings and revenue history

Current Revenue
$8.2M
Current Earnings
-$32.5M
Current Profit Margin
-394.9%

CLSD Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when CLSD announces earnings.

CLSD Return on Assets

Current Company
-85.3%
Current Industry
2.9%
CLSD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CLSD Return on Capital Employed

Current Company
-119.41%
Current Industry
19.5%
CLSD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CLSD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CLSD$8.23M-$32.42M-$32.49M+207.34%N/A
CLRB$0.00-$37.79M-$37.98MN/AN/A
BRNS$802.00k-$69.64M-$73.35M-41.49%N/A
IOBT$0.00-$84.48M-$86.08MN/AN/A
PDSB$0.00-$42.87M-$42.94MN/AN/A
View Top Biotech Stocks

CLSD earnings dates

Next earnings date
May 9, 2024

Clearside Biomedical Earnings & Revenue FAQ

What were CLSD's earnings last quarter?

On Invalid Date, Clearside Biomedical (NASDAQ: CLSD) reported Q4 2023 earnings per share (EPS) of -$0.08, up 50% year over year. Total Clearside Biomedical earnings for the quarter were -$4.83 million. In the same quarter last year, Clearside Biomedical's earnings per share (EPS) was -$0.16.

If you're new to stock investing, here's how to buy Clearside Biomedical stock.

What was CLSD's earnings growth in the past year?

As of Q2 2024, Clearside Biomedical's earnings has grown year over year. Clearside Biomedical's earnings in the past year totalled -$32.49 million.

What is CLSD's earnings date?

Clearside Biomedical's earnings date is Invalid Date. Add CLSD to your watchlist to be reminded of CLSD's next earnings announcement.

What was CLSD's revenue last quarter?

On Invalid Date, Clearside Biomedical (NASDAQ: CLSD) reported Q4 2023 revenue of $6.35 million up 1,822.73% year over year. In the same quarter last year, Clearside Biomedical's revenue was $330.00 thousand.

What was CLSD's revenue growth in the past year?

As of Q2 2024, Clearside Biomedical's revenue has grown 519.89% year over year. This is 370.38 percentage points higher than the US Biotechnology industry revenue growth rate of 149.51%. Clearside Biomedical's revenue in the past year totalled $8.23 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.